Fulgent Genetics, Inc.FLGT

時価総額

$6.6億

PER

	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Revenue	18	19	21	33	422	993	619
Cost of revenue	7	9	11	14	90	216	252
Gross profit	12	10	11	18	332	777	367
Research and development	4	4	6	7	12	24	29
Selling and marketing	2	4	5	6	15	24	39
General and administrative	5	5	6	6	15	51	111
Amortization of intangible assets	-	-	-	-	-	2	6
Restructuring costs	-	-	-	-	-	-	3
Total operating expenses	11	14	16	19	42	101	188
Operating (loss) income	1	-3	-5	-0	290	676	179
Interest and Other Income	-	-	-	1	2	1	5
Income before income taxes and gain on equity method investment	-4	-3	-5	0	292	677	184
Provision for income taxes	1	-1	0	0	73	175	42
Income before gain on equity method investment	-	-	-	-	-	503	142
Equity loss in investee	-	-1	-1	-1	-0	-	-
Gain Loss On Equity Method Investments	-	-	-	-	-	4	-
Net income from consolidated operations	-	-	-6	-0	214	506	142
Net loss attributable to noncontrolling interests	-	-	-	-	-	-1	-1
Net income attributable to Fulgent	-5	-3	-6	-0	214	507	143
Basic	-	-	-	-0.02	9.44	17.25	4.76
Diluted	-	-	-	-0.02	8.91	16.38	4.63